BIO 2015 Dispatches: Acorda CEO Cohen to bring 'passion' to BIO chairmanship
This article was originally published in Scrip
Executive Summary
The board of directors for the Biotechnology Industry Organization (BIO) on 15 June opened its annual meeting in Philadelphia by electing Dr Ron Cohen, president and CEO of Acorda Therapeutics, as the group's new chairman for 2015-16.